{"title": "Candidate targets for immune responses to 2019-Novel Coronavirus (nCoV): sequence homology- and bioinformatic-based predictions", "doi": "10.1101/2020.02.12.946087", "citation_id": "2020.02.12.946087v3", "date": "2020-03-16", "laguage": "en", "journal_title": "bioRxiv", "first_page": "2020.02.12.946087", "abstract": "<p>Effective countermeasures against the recent emergence and rapid expansion of the 2019-Novel Coronavirus (2019-nCoV) require the development of data and tools to understand and monitor viral spread and immune responses. However, little information about the targets of immune responses to 2019-nCoV is available. We used the Immune Epitope Database and Analysis Resource (IEDB) resource to catalog available data related to other coronaviruses, including SARS-CoV, which has high sequence similarity to 2019-nCoV, and is the best-characterized coronavirus in terms of epitope responses. We identified multiple specific regions in 2019-nCoV that have high homology to SARS virus. Parallel bionformatic predictions identified a priori potential B and T cell epitopes for 2019-nCoV. The independent identification of the same regions using two approaches reflects the high probability that these regions are targets for immune recognition of 2019-nCoV.</p>", "twitter_description": "Effective countermeasures against the recent emergence and rapid expansion of the 2019-Novel Coronavirus (2019-nCoV) require the development of data and tools to understand and monitor viral spread and immune responses. However, little information about the targets of immune responses to 2019-nCoV is available. We used the Immune Epitope Database and Analysis Resource (IEDB) resource to catalog available data related to other coronaviruses, including SARS-CoV, which has high sequence similarity to 2019-nCoV, and is the best-characterized coronavirus in terms of epitope responses. We identified multiple specific regions in 2019-nCoV that have high homology to SARS virus. Parallel bionformatic predictions identified a priori potential B and T cell epitopes for 2019-nCoV. The independent identification of the same regions using two approaches reflects the high probability that these regions are targets for immune recognition of 2019-nCoV.\n\nONE SENTENCE SUMMARY We identified potential targets for immune responses to 2019-nCoV and provide essential information for understanding human immune responses to this virus and evaluation of diagnostic and vaccine candidates.", "full_text_html_url": "https://www.biorxiv.org/content/10.1101/2020.02.12.946087v3.full", "public_url": "https://www.biorxiv.org/content/10.1101/2020.02.12.946087v3", "abstract_html_url": "https://www.biorxiv.org/content/10.1101/2020.02.12.946087v3.abstract", "pdf_url": "https://www.biorxiv.org/content/biorxiv/early/2020/03/16/2020.02.12.946087.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/", "publisher": "Cold Spring Harbor Laboratory", "pisa": "biorxiv;2020.02.12.946087v3", "access_rights": "restricted", "authors": ["Alba Grifoni", "John Sidney", "Yun Zhang", "Richard H Scheuermann", "Bjoern Peters", "Alessandro Sette"]}